Jinhe Biotechnology CO., LTD. (SHE:002688)
China
· Delayed Price · Currency is CNY 6.02
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:002688 Revenue
In the year 2025, Jinhe Biotechnology CO., LTD. had annual revenue of 2.88B CNY with 21.41% growth. Jinhe Biotechnology CO., LTD. had revenue of 841.90M in the quarter ending December 31, 2025, with 18.02% growth.
Revenue
2.88B
Revenue Growth
+21.41%
P/S Ratio
1.57
Revenue / Employee
1.16M
Employees
2,476
Market Cap
4.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.88B | 507.47M | 21.41% |
| Dec 31, 2024 | 2.37B | 196.50M | 9.04% |
| Dec 31, 2023 | 2.17B | 51.43M | 2.42% |
| Jan 1, 2023 | 2.12B | 44.72M | 2.15% |
| Jan 1, 2022 | 2.08B | 263.35M | 14.51% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Newland Pharmaceutical | 659.54M |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Jinling Pharmaceutical Company | 3.16B |
| Tibet Weixinkang Medicine | 1.16B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 543.82M |
| Shandong Wohua Pharmaceutical | 818.16M |
| Shandong Sinobioway Biomedicine | 274.81M |